CNLM-539-H-PK 氨基酸 -¹³C?, ¹?N?
- 公司名稱 熱耳（北京）科技有限公司
- 品牌 CIL/美國
- 型號 CNLM-539-H-PK
- 產(chǎn)地 美國
- 廠商性質(zhì) 代理商
- 更新時(shí)間 2024/11/29 16:03:54
- 訪問次數(shù) 160
聯(lián)系我們時(shí)請說明是化工儀器網(wǎng)上看到的信息，謝謝!
穩(wěn)定同位素標(biāo)記產(chǎn)品，氨基酸，維生素，膽汁酸，激素，環(huán)境標(biāo)準(zhǔn)品，氘代試劑，同位素金屬，氣體，秸稈等
| CAS | 202468-25-5 | 供貨周期 | 現(xiàn)貨 |
|---|---|---|---|
| 應(yīng)用領(lǐng)域 | 生物產(chǎn)業(yè),制藥/生物制藥,綜合 | 主要用途 | 蛋白定量 |
SILAC 即細(xì)胞培養(yǎng)條件下 穩(wěn)定同位素標(biāo)記技術(shù) (Stable isotope labeling with amino acids in cell culture，SILAC)，其基本原理是在細(xì)胞培養(yǎng)時(shí)，采用含有輕、中、重同位素型必需氨基酸的培養(yǎng)基進(jìn)行細(xì)胞培養(yǎng)，用于SILAC主要的穩(wěn)定同位素氨基酸是Lys和Arg, 細(xì)胞在傳代培養(yǎng)過程中同位素氨基酸將被細(xì)胞用于合成蛋白質(zhì)，細(xì)胞經(jīng)傳代培養(yǎng)5-6代后，細(xì)胞的所有蛋白質(zhì)將被同位素標(biāo)記，等量混合標(biāo)記的蛋白質(zhì)后經(jīng)過SDS-PAGE分離和質(zhì)譜分析，通過比較一級質(zhì)譜圖中三個(gè)同位素型肽段的面積大小進(jìn)行相對定量，同時(shí)二級譜圖對肽段進(jìn)行序列測定從而鑒定蛋白質(zhì)。
CLM-2247-H-0.05L-Lysine·2HCl (13C?, 99%)
CLM-2247-H-0.1L-Lysine·2HCl (13C?, 99%)
CLM-2247-H-0.25L-Lysine·2HCl (13C?, 99%)
CLM-2247-H-0.5L-Lysine·2HCl (13C?, 99%)
CLM-2247-H-1L-Lysine·2HCl (13C?, 99%)
CLM-2247-H-PKL-Lysine·2HCl (13C?, 99%)
CLM-2262-H-PKL-Leucine (13C?, 99%)
CLM-2263-H-0.1L-Tyrosine (13C?, 99%)
CLM-2263-H-0.25L-Tyrosine (13C?, 99%)
CLM-2263-H-0.5L-Tyrosine (13C?, 99%)
CLM-2263-H-PKL-Tyrosine (13C?, 99%)
CLM-2265-H-0.05L-Arginine·HCl (13C?, 99%)
CLM-2265-H-0.1L-Arginine·HCl (13C?, 99%)
CLM-2265-H-0.25L-Arginine·HCl (13C?, 99%)
CLM-2265-H-0.5L-Arginine·HCl (13C?, 99%)
CLM-2265-H-1L-Arginine·HCl (13C?, 99%)
CLM-2265-H-PKL-Arginine·HCl (13C?, 99%)
CNLM-10424-0.01β-??-Methylamino-L-alanine (13C?, 99%; 1?N?, 98%) US patent pending: 62/368,562
CNLM-10424-PKβ-??-Methylamino-L-alanine (13C?, 99%; 1?N?, 98%) US patent pending: 62/368,562
CNLM-11110-PKL-Arginine·HCl (1,2,3,4,5-13C?, 99%; α,ε-1?N?, 98%)
CNLM-281-H-0.05L-Leucine (13C?, 99%; 1?N, 99%)
CNLM-281-H-0.1L-Leucine (13C?, 99%; 1?N, 99%)
CNLM-281-H-0.25L-Leucine (13C?, 99%; 1?N, 99%)
CNLM-281-H-PKL-Leucine (13C?, 99%; 1?N, 99%)
CNLM-291-H-0.05L-Lysine·2HCl (13C?, 99%; 1?N?, 99%)
CNLM-291-H-0.1L-Lysine·2HCl (13C?, 99%; 1?N?, 99%)
CNLM-291-H-0.25L-Lysine·2HCl (13C?, 99%; 1?N?, 99%)
CNLM-291-H-0.5L-Lysine·2HCl (13C?, 99%; 1?N?, 99%)
CNLM-291-H-1L-Lysine·2HCl (13C?, 99%; 1?N?, 99%)
CNLM-291-H-PKL-Lysine·2HCl (13C?, 99%; 1?N?, 99%)
CNLM-439-H-0.1L-Tyrosine (13C?, 99%; 1?N, 99%)
CNLM-439-H-0.25L-Tyrosine (13C?, 99%; 1?N, 99%)
CNLM-439-H-0.5L-Tyrosine (13C?, 99%; 1?N, 99%)
CNLM-439-H-PKL-Tyrosine (13C?, 99%; 1?N, 99%)
CNLM-474-H-0.1L-Serine (13C?, 99%; 1?N, 99%)
CNLM-474-H-0.25L-Serine (13C?, 99%; 1?N, 99%)
CNLM-474-H-0.5L-Serine (13C?, 99%; 1?N, 99%)
CNLM-474-H-PKL-Serine (13C?, 99%; 1?N, 99%)
CNLM-539-H-0.05L-Arginine·HCl (13C?, 99%; 1?N?, 99%)
CNLM-539-H-0.1L-Arginine·HCl (13C?, 99%; 1?N?, 99%)
CNLM-539-H-0.25L-Arginine·HCl (13C?, 99%; 1?N?, 99%)
CNLM-539-H-0.5L-Arginine·HCl (13C?, 99%; 1?N?, 99%)
CNLM-539-H-1L-Arginine·HCl (13C?, 99%; 1?N?, 99%)
CNLM-539-H-PKL-Arginine·HCl (13C?, 99%; 1?N?, 99%)
CNLM-561-H-PKL-Isoleucine (13C?, 99%; 1?N, 99%)
CNLM-7579-PKL-Cysteine, ??-acetyl (cysteine-13C?, 97-99%; 1?N, 97-99%) CP 95%
DLM-10483-PKGlycine, ??-isovaleryl (isovaleryl-D?, 98%)
DLM-2640-0.1L-Lysine·2HCl (4,4,5,5-D?, 96-98%)
DLM-2640-0.25L-Lysine·2HCl (4,4,5,5-D?, 96-98%)
DLM-2640-0.5L-Lysine·2HCl (4,4,5,5-D?, 96-98%)
DLM-2640-1L-Lysine·2HCl (4,4,5,5-D?, 96-98%)
DLM-2640-PKL-Lysine·2HCl (4,4,5,5-D?, 96-98%)
DLM-2641-0.25L-Lysine·2HCl (3,3,4,4,5,5,6,6-D?, 98%)
DLM-2641-PKL-Lysine·2HCl (3,3,4,4,5,5,6,6-D?, 98%)
DLM-4731-PKL-Lysine, NE-carboxymethyl (4,4,5,5-D?, 96-98%)
DLM-6108-0.01DL-Cystathionine (3,3,4,4-D?, 98%)
DLM-6108-0.05DL-Cystathionine (3,3,4,4-D?, 98%)
DLM-6108-PKDL-Cystathionine (3,3,4,4-D?, 98%)
DLM-7703-0.1Glycine, ??-benzoyl (hippuric acid) (benzoyl-D?, 98%)
DLM-7703-0.25Glycine, ??-benzoyl (hippuric acid) (benzoyl-D?, 98%)
DLM-7703-PKGlycine, ??-benzoyl (hippuric acid) (benzoyl-D?, 98%)
DLM-9715-PK??-(3-Phenylpropionyl)glycine (2,2,-D?, 98%)
DNLM-7543-0.25L-Arginine·HCl (D?, 98%; 1?N?, 98%)
DNLM-7543-PKL-Arginine·HCl (D?, 98%; 1?N?, 98%)
DNLM-7545-0.25L-Lysine·2HCl (D?, 98%; 1?N?, 98%)
采購中心
化工儀器網(wǎng)